النقدية وما يعادلها تغيير تاريخ
Acadia Pharmaceuticals USD 819.69M 27.33M 2025-12
Agios Pharmaceuticals USD 113.6M 24.47M 2026-03
Akebia Therapeutics USD 184.84M 18.4M 2025-12
Almirall EUR 337.77M 14.83M 2025-12
Alnylam Pharmaceuticals USD 1.71B 53.53M 2026-03
Amarin USD 131.06M 3.6M 2026-03
Ardelyx USD 31.21M 36.79M 2026-03
Astellas Pharma JPY 188.37B 8.51B 2025-03
AstraZeneca USD 7.56B 1.85B 2026-03
Charles River Laboratories USD 213.77M 6.67M 2025-12
Coherus Biosciences USD 88.88M 14.47M 2025-12
Emergent BioSolutions USD 111.7M 23.9M 2023-12
Esperion Therapeutics USD 92.45M 6.39M 2025-09
Halozyme Therapeutics USD 133.82M 285.84M 2025-12
Incyte USD 4.02B 435.22M 2026-03
Ironwood Pharmaceuticals USD 140.41M 47.56M 2025-09
Karyopharm Therapeutics USD 60.54M 22.87M 2025-12
Lexicon Pharmaceuticals USD 21.36M 41.52M 2025-06
MacroGenics USD 57.22M 22.91M 2025-12
Moderna USD 1.91B 687M 2026-03
Myriad Genetics USD 124.4M 25.2M 2026-03
Pacira USD 144.31M 14.24M 2026-03
PTC Therapeutics USD 984.65M 312.03M 2025-12
Puma Biotechnology USD 53.52M 1.14M 2025-09
Sarepta Therapeutics USD 801.28M 188.2M 2025-12
Takeda JPY 654.94B 26.55B 2025-12
Ultragenyx Pharmaceutical USD 175M 246M 2026-03
Vanda Pharmaceuticals USD 84.85M 14.83M 2025-12